台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    38.80
  • 漲跌
    ▲0.70
  • 漲幅
    +1.84%
  • 成交量
    161
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-富邦-南屯 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/203537.54042.54547.550May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

富邦-南屯 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/28040.5000.0039.6001570.00%
2025/03/25042.1800.0041.5501490.00%
2025/03/24042.4000.0041.8001490.00%
2025/02/26045.9500.0045.8001500.00%
2025/02/21046.6000.0045.4001530.00%
2025/02/20045.3000.0045.2501480.00%
2025/02/19044.10244.5044.30-2157-1.27%
2025/02/12044.1800.0044.0501680.00%
2025/02/10044.7000.0043.7501790.00%
2025/01/20043.9500.0041.6503780.00%
2024/12/26144.10144.3044.0504290.00%
2024/10/28454.752155.6652.60-17756-2.25%
2024/10/252054.40252.9554.40186452.79%
2024/10/21050.0000.0049.9006600.00%
2024/10/1600.00150.1050.60-1961-0.10%
2024/10/1400.00250.5050.40-21,057-0.19%
2024/09/3000.00155.5054.40-11,046-0.10%
2024/09/2600.00252.2051.90-21,023-0.20%
2024/09/2500.00153.8053.80-11,018-0.10%
2024/09/23155.10155.5054.6001,0190.00%
2024/09/2000.00254.6555.00-21,023-0.20%
2024/09/19354.4300.0053.2039950.30%
2024/09/1600.00147.6047.60-1943-0.11%
2024/09/13147.8000.0047.8019670.10%
2024/09/09149.15149.0048.2001,0340.00%
2024/08/3000.00150.5051.30-1999-0.10%
2024/08/28149.7500.0050.3019810.10%
2024/08/2300.00149.0549.35-1966-0.10%
2024/08/20149.3000.0050.9019430.11%
2024/08/1900.00249.8049.80-2930-0.21%
2024/08/1300.00347.2047.10-3894-0.34%
2024/08/12048.5500.0048.1508850.00%
2024/08/09249.60250.0048.1508790.00%
2024/08/08149.2000.0049.7518650.12%
2024/08/07250.5000.0050.7028560.23%
2024/08/0600.00148.6049.00-1841-0.12%
2024/07/31156.1000.0056.5017990.13%
2024/07/23154.8000.0054.1017700.13%
2024/07/19259.40159.6058.1017350.14%
2024/07/18258.3500.0062.2026580.30%
2024/07/17858.50158.4058.9075431.29%
2024/07/16156.5000.0057.2014270.23%
2024/07/080.145.0000.0044.700.13150.03%
2024/06/25245.60844.3145.20-6264-2.27%
2024/06/213.547.1400.0045.203.52581.35%
2024/06/204.348.63247.9047.602.32500.91%
2024/06/19248.00545.0047.95-3224-1.33%
2024/06/18544.36445.3344.0012130.47%
2024/06/17444.9100.0045.3541872.14%
2024/05/3000.00042.7041.3501600.00%
2024/05/2300.00042.1542.1001720.00%
2024/05/2200.00243.1043.25-2174-1.14%
2024/05/0300.00342.3041.75-3182-1.65%
2024/04/19340.5000.0040.7031861.61%
2024/04/18042.5000.0041.9001820.00%
2024/04/15042.6500.0042.3001870.00%
2024/04/12043.9500.0043.3001860.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音
 
 
420小時50